Drug Safety Panel Urges New Entity To Oversee Japan Drug Approvals
This article was originally published in The Pink Sheet Daily
Executive Summary
The independent, neutral body would be charged with monitoring, inspecting and investigating MHLW, the Pharmaceutical and Medical Devices Agency and other government administrative functions.